1
68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)
Condition(s):Prostate Cancer MetastaticLast Updated:November 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer MetastaticLast Updated:November 17, 2020Completed
Condition(s):Prostate Adenocarcinoma; PSA Progression; Recurrent Prostate CarcinomaLast Updated:January 30, 2024Completed
Condition(s):Prostatic NeoplasmLast Updated:March 22, 2023Terminated
Condition(s):Metastatic Castration-resistant Prostate Cancer (mCRPC)Last Updated:February 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.